Chemoinformaics analysis of 18-Beta-hydroxy-3-epi-alpha-yohimbine
| Molecular Weight | 370.449 | nRot | 1 |
| Heavy Atom Molecular Weight | 344.241 | nRig | 26 |
| Exact Molecular Weight | 370.189 | nRing | 5 |
| Solubility: LogS | -2.301 | nHRing | 3 |
| Solubility: LogP | 2.131 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 10 |
| nHA | 5 | APOL | 57.8146 |
| nHD | 3 | BPOL | 30.9674 |
| QED | 0.664 |
| Synth | 4.108 |
| Natural Product Likeliness | 1.22 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.022 |
| Pgp-sub | 0.997 |
| HIA | 0.009 |
| CACO-2 | -5.687 |
| MDCK | 0.0000113 |
| BBB | 0.478 |
| PPB | 0.64766 |
| VDSS | 1.552 |
| FU | 0.414516 |
| CYP1A2-inh | 0.323 |
| CYP1A2-sub | 0.853 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.842 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.541 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.872 |
| CYP3a4-inh | 0.046 |
| CYP3a4-sub | 0.63 |
| CL | 7.206 |
| T12 | 0.832 |
| hERG | 0.726 |
| Ames | 0.033 |
| ROA | 0.489 |
| SkinSen | 0.207 |
| Carcinogencity | 0.141 |
| EI | 0.026 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.590926 |